Patents by Inventor Werhner C. Orilla
Werhner C. Orilla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9039761Abstract: Ocular implant delivery assemblies are provided which include a cannula having a lumen extending therethrough, a proximal end, a proximal end opening, a distal end, a distal end opening, and a lumen extending through the cannula. A cap is provided having a closed distal end, being in contact with the outer wall of the cannula, and covering the distal end and the distal end opening of the cannula, the cap being structured to allow the distal end and the distal end opening of the cannula to pass through the cap as the cannula is passed into an eye. An ocular implant is located in the lumen. The implant may be sealed in the cannula without the addition of a liquid carrier or it may be contained in a liquid carrier medium in the cannula. The implant may be made up of a number of microparticles having different compositions or different forms. The assembly also includes a sleeve located on the proximal end of the cannula and suitable for coupling the assembly to a syringe containing a pushing gel.Type: GrantFiled: October 25, 2006Date of Patent: May 26, 2015Assignee: Allergan, Inc.Inventors: John T. Trogden, Robert T. Lyons, James N. Chang, Michael R. Robinson, Werhner C. Orilla
-
Patent number: 8969415Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 10 days and one year or longer.Type: GrantFiled: December 1, 2006Date of Patent: March 3, 2015Assignee: Allergan, Inc.Inventors: Michael R. Robinson, Wendy M. Blanda, Patrick M. Hughes, Guadalupe Ruiz, Werhner C. Orilla, Scott M. Whitcup, Devin F. Welty, Joan-En Lin, Lon T. Spada
-
Publication number: 20140341968Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 10 days and one year or longer.Type: ApplicationFiled: August 1, 2014Publication date: November 20, 2014Inventors: Michael R. Robinson, Wendy M. Blanda, Patrick M. Hughes, Guadalupe Ruiz, Werhner C. Orilla, Scott M. Whitcup, Lon T. Spada, Devin F. Welty, Joan-En Lin
-
Publication number: 20140038972Abstract: Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants can be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, including reduction of an elevated intraocular pressure.Type: ApplicationFiled: August 30, 2013Publication date: February 6, 2014Applicant: Allergan, Inc.Inventors: James N. Chang, Lon T. Spada, Wendy M. Blanda, Werhner C. Orilla, James A. Burke, Patrick M. Hughes
-
Patent number: 8529927Abstract: Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants can be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, including reduction of an elevated intraocular pressure.Type: GrantFiled: March 31, 2006Date of Patent: September 10, 2013Assignee: Allergan, Inc.Inventors: James N. Chang, Lon T. Spada, Wendy M. Blanda, Werhner C. Orilla, James A. Burke, Patrick M. Hughes
-
Patent number: 8353862Abstract: A delivery system includes a housing along with a tip connected to one end of the housing. A first cannula extending from the tip is provided for inserting a rod implant into tissue. A second cannula, concentrically disposed within the first cannula, is utilized to force the rod implant from the first cannula and for ejecting a fluid behind the inserted rod implant in the tissue.Type: GrantFiled: November 2, 2007Date of Patent: January 15, 2013Assignee: Allergan, Inc.Inventors: Werhner C. Orilla, James A. Burke
-
Publication number: 20120245505Abstract: Described herein are intracameral drug and/or therapeutic bioactive agent delivery devices comprising a substantially cylindrical structure for at least partial placement into the anterior chamber of an eye The intracameral delivery devices have a sustained release material associated with at least a portion of the device and at least one drug and/or therapeutic bioactive agent associated with said sustained release material.Type: ApplicationFiled: December 14, 2010Publication date: September 27, 2012Inventors: Michael R. Robinson, Werhner C. Orilla, Zoran Novakovic, James A. Burke, Alazar N. Ghebremeskel, Lon T. Spada
-
Publication number: 20100247606Abstract: Biocompatible, bioerodible sustained release implants and microspheres for intracameral or anterior vitreal placement include an anti-hypertensive agent and a biodegradable polymer effective to treat an ocular hypertensive condition (such as glaucoma) by relapsing therapeutic amount of the anti-hypertensive agent over a period of time between 10 days and 1 year.Type: ApplicationFiled: March 25, 2009Publication date: September 30, 2010Applicant: ALLERGAN, INC.Inventors: Michael R. ROBINSON, James A. Burke, Hui Liu, Werhner C. Orilla, Lon T. Spada, Scott Whitcup, Alazar N. Ghebremskel, Patrick M. Hughes, Kun Xu, Marianne M. Do
-
Publication number: 20090118703Abstract: A delivery system includes a housing along with a tip connected to one end of the housing. A first cannula extending from the tip is provided for inserting a rod implant into tissue. A second cannula, concentrically disposed within the first cannula, is utilized to force the rod implant from the first cannula and for ejecting a fluid behind the inserted rod implant in the tissue.Type: ApplicationFiled: November 2, 2007Publication date: May 7, 2009Inventors: WERHNER C. ORILLA, JAMES A. BURKE
-
Publication number: 20090082796Abstract: A tenotomy scissors for implantation procedures generally includes a first blade having a handle and a tip with a cutting edge thereon, a second blade having a handle and a tip with a cutting edge thereon, along with a swivel pivotally attaching the first and second blades for enabling insertion of the cutting edges for cutting a pocket in tissue when the handle is operated. One or more risers upstanding from at least one of the blade tips are provided for keeping the pocket open to facilitate insertion of an implant device.Type: ApplicationFiled: September 21, 2007Publication date: March 26, 2009Applicant: ALLERGAN, INC.Inventors: WERHNER C. ORILLA, Michael R. Robinson
-
Publication number: 20090004244Abstract: A contact lens providing zonal drug delivery includes a lens body having an optical axis and an opaque simulated iris pattern applied to the lens body, about the optical axis, with the pattern including an ophthalmic drug.Type: ApplicationFiled: June 27, 2007Publication date: January 1, 2009Inventors: Werhner C. Orilla, James A. Burke
-
Publication number: 20090004245Abstract: A drug delivery device includes a contact lens along with a drug delivery zone disposed above an applied axis of the lens. A colored layer is disposed over the drug delivery zone in order to mark a color of the drug delivery zone.Type: ApplicationFiled: June 28, 2007Publication date: January 1, 2009Inventors: Werhner C. Orilla, Michael R. Robinson, James A. Burke
-
Publication number: 20080317819Abstract: A contact lens for delivery of a multiplicity of drugs includes a lens body with a first drug incorporated in a first zonal area of the lens body and a second drug incorporated in a second zonal area of the lens body. The first and second drugs are dissimilar and the first and second zonal areas are spaced apart from one another.Type: ApplicationFiled: June 21, 2007Publication date: December 25, 2008Inventors: Werhner C. Orilla, Michael Robinson, James Burke
-
Publication number: 20080131484Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 10 days and one year or longer.Type: ApplicationFiled: December 1, 2006Publication date: June 5, 2008Applicant: ALLERGAN, INC.Inventors: Michael R. Robinson, Wendy M. Blanda, Patrick M. Hughes, Guadalupe Ruiz, Werhner C. Orilla, Scott M. Whitcup
-
Publication number: 20080107713Abstract: A drug delivery device includes a contact lens having an optical axis and a plurality of discrete drug delivery zones asymmetrically disposed about the optical axis. A weighted area is provided in the contact lens for maintaining a presence of the contact lens upper hemispherical region in position with an upper hemispherical region of the user's eye. The asymmetrically disposed discrete drug delivery zones are positioned in the upper hemispherical region of the contact lens.Type: ApplicationFiled: November 8, 2006Publication date: May 8, 2008Inventors: Werhner C. Orilla, James Burke, Michael Robinson
-
Publication number: 20080033351Abstract: Ocular implant delivery assemblies are provided which include a cannula having a lumen extending therethrough, a proximal end, a proximal end opening, a distal end, a distal end opening, and a lumen extending through the cannula. A cap is provided having a closed distal end, being in contact with the outer wall of the cannula, and covering the distal end and the distal end opening of the cannula, the cap being structured to allow the distal end and the distal end opening of the cannula to pass through the cap as the cannula is passed into an eye. An ocular implant is located in the lumen. The implant may be sealed in the cannula without the addition of a liquid carrier or it may be contained in a liquid carrier medium in the cannula. The implant may be made up of a number of microparticles having different compositions or different forms. The assembly also includes a sleeve located on the proximal end of the cannula and suitable for coupling the assembly to a syringe containing a pushing gel.Type: ApplicationFiled: October 25, 2006Publication date: February 7, 2008Applicant: ALLERGAN, INC.Inventors: John T. Trogden, Robert T. Lyons, James N. Chang, Michael R. Robinson, Werhner C. Orilla